ClearPoint Neuro (CLPT) Cost of Revenue (2011 - 2026)
ClearPoint Neuro (CLPT) posted Cost of Revenue of $4.4 million for Q1 2026, up 9.14% sequentially from $4.0 million in Q4 2025, and up 30.39% YoY from $3.4 million in Q1 2025.
ClearPoint Neuro (CLPT) Cost of Revenue (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Cost of Revenue for 15 years, with the latest figure at $4.4 million in Q1 2026.
- Quarterly Cost of Revenue rose 30.39% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 22.32% YoY) and the FY2025 annual result came in at $14.3 million, up 16.39% from the prior year.
- Cost of Revenue rose to $4.4 million in Q1 2026 per CLPT's latest filing, from $4.0 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $4.4 million in Q1 2026 and troughed at $1.5 million in Q3 2022.
- A 5-year average of $2.8 million and a median of $2.9 million in 2024 frame the typical range for Cost of Revenue.
- The widest YoY moves for Cost of Revenue: up 70.76% in 2022, down 4.31% in 2022.
- Over 5 years, Cost of Revenue stood at $1.8 million in 2022, then jumped by 54.7% to $2.8 million in 2023, then climbed by 7.58% to $3.0 million in 2024, then surged by 33.13% to $4.0 million in 2025, then rose by 9.14% to $4.4 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $4.4 million, $4.0 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|